TCL Archive In Brief: Increasing Survival Through Adjuvant Therapy Seen As Adding To Cost Of Care October 24, 1975
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Feds Set Guidelines For Pharma To Help Patients With Cost Of Drugs, While Steering Clear Of Anti-Kickback Law. April 28, 2006
TCL Archive In Brief: Gigliotti Named Greenwald Special Assistant; Coltman To Get ACCC Clinical Research Award August 26, 1988
